Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Diffuse Intrinsic Pontine Glioma × Blood Specimen Collection × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Glioma 1 Epidural Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Alzheimer Disease 1

Interventions

Gemcitabine 2 lorlatinib 1 larotrectinib 1 fimepinostat 1 Temozolomide 1 Irinotecan 1 CUDC-907 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04051047 2019-11-27

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Withdrawn

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡